EasyDiagnosis’ Post

Register for our webinar to learn more about how anti-RA33 autoantibodies are improving test accuracy for seronegative #rheumatoidarthritis patients. #autoimmunedisease #rheumatology https://ow.ly/aJW750UaxNP

With #LungCancer causing 1.8 million deaths globally each year, innovations in immunotherapy and targeted therapies are reshaping patient care. However, collaboration among healthcare professionals to progress early detection, solve current challenges in therapy approaches, and provide improved patient support is crucial to advancing the treatment landscape further. On #WorldLungCancerDay, let's acknowledge the advancements transforming the field 🌎🫁 ➡️ https://lnkd.in/eM8YCqWE

💫 #ONCOnews 💫 🌟 Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS 👉 RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible (serum EPO >500 mU/mL) 🔗 https://buff.ly/3yhibvg #OncEd #OncoAlert

"This is what really matters to patients when time becomes more limited and more valued." #behindpatienteyes By understanding what really is important to patients and their caregivers and by asking enough of them in a meaningful way, we can better support patients. It was interesting to see in yesterdays post that fear/depression was considered the most burdensome aspect for those cancer patients, and that the burden due to visits to the doctor was rated higher than symptoms of the disease.   This is what really matters to patients when time becomes more limited and more valued. #behindpatienteyes These are areas that healthcare, pharma and patient groups can directly support to improve if they work with patients, their caregivers and healthcare professionals. Patients can provide valuable input into what was positive and negative in their diagnosis journey, what information and options they were provided with, the clinical trial options that were offered, why they did or did not consider clinical trials, their treatment experience and their experience as their patient journey continued. Each patient in each indication, country and community will have a different story to share. From future approaches to diagnosis, to ways to communicate options and treatment pathways, patients can offer valuable insights to help reduce fear / stress and create a higher quality patient journey. #patientengagement #healthcare #patientjourney #patientinsights #clinicaldevelopment #medicalaffairs #patienteducation

Let's not overlook the importance of biomarker testing in TNBC treatment decisions. It's essential for personalizing care, improving outcomes, and enhancing the quality of life for patients. https://ow.ly/qqJm50Sghnx #biomarkertesting #precisionmedicine #TNBCawareness

It's Week 3 of #BreastCancerAwarenessMonthWeek and this week we are going to highlight some of the issues that #MetastaticBreastCancer patients face around clinical trials. Clinical trials represent hope for MBC patients - they could be the first to access a new life-extending treatment. But there are issues in finding and accessing clinical trials. Our patient blogs this week highlight the issues that we face... The joy of getting on a trial to the sadness and the upset of it not working or being denied because you have had too many treatments already and not deemed "fit enough" to be accepted on a trial... #WhoReallyCares #BreastCancerAwarenessMonth #BCAM #costofliving #severitymodifier #METUPUK #DarkerPink #BusyLivingWithMets #IAmThe31 #waitingroomfeet #BreastCancer #BreastCancerCommunity #BreastCancerJourney #BreastCancerSupport #DyingForACure #EarlyDetectionSavesLives #MetastaticBreastCancerAwareness #SecondaryBreastCancer #SecondarySisters #Stage4NeedsMore #StageIVNeedsMore #AdvancedBreastCancer #clinicaltrials

Navigating the healthcare system during a cancer diagnosis is challenging—for anyone. Beyond the financial strain, the emotional, physical, and logistical burdens can feel insurmountable. Kadance was created to give your clients the support they need during these difficult times. With tools like advanced genomic profiling, 1:1 Oncology Nurse Navigation, and a tailored Medication Optimization Program, Kadance helps your clients focus on their health, not their challenges. By bringing Kadance into your portfolio, you provide more than just insurance—you provide access to high-quality care and guidance when it’s needed most. Connect with us today to learn more about how Kadance can enhance the value you bring to your clients. #Kadance #InsuranceTech #LivingBenefits #PrecisionHealth #InnovativeBenefits

Upfront Diagnostics is set to launch a ground-breaking lateral flow test for stroke patients in 2025. 💭💡 This rapid and accurate diagnostic tool aims to revolutionise stroke diagnosis, enabling timely interventions crucial for improving patient outcomes. Sign up for our #POCWeekly newsletter to stay updated on this game-changing development in stroke care along with other breaking news stories within the market. (link in the comments below) #diagnostics #pointofcare #lateralflow

For US #HCPs at #EHA2024: don’t miss Dr. Wilfried Roeloffzen present efficacy & safety results from Cohort D of the Phase 2 CARTITUDE-2 study, investigating a BCMA CAR-T therapy in patients with newly diagnosed #MultipleMyeloma & suboptimal response to frontline ASCT. Click here to see the presentation: https://lnkd.in/e2aJqRtM

The recent publication of the economic evaluation I co-authored is receiving excellent coverage. For more information on how Paramedics and Palliative Care address the needs of healthcare providers, patients, families, and the healthcare system, please explore the links below! The Wire - https://lnkd.in/gKU6uKj6 The Conversation - https://lnkd.in/gQJj-izm